These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 18962846

  • 1. Phase I trial of the treatment of high-risk endometrial cancer with concurrent weekly paclitaxel and cisplatin and whole abdominal radiation therapy: a Gynecologic Oncology Group study.
    McMeekin DS, Walker JL, Hartenbach EM, Bookman MA, Koh WJ, Gynecologic Oncology Group.
    Gynecol Oncol; 2009 Jan; 112(1):134-41. PubMed ID: 18962846
    [Abstract] [Full Text] [Related]

  • 2. A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer.
    Duska LR, Berkowitz R, Matulonis U, Muto M, Goodman A, McIntyre JF, Klein A, Atkinson T, Seiden MV, Campos S.
    Gynecol Oncol; 2005 Jan; 96(1):198-203. PubMed ID: 15589601
    [Abstract] [Full Text] [Related]

  • 3. Feasibility study of concurrent weekly cisplatin and whole abdominopelvic irradiation followed by doxorubicin/cisplatin chemotherapy for advanced stage endometrial carcinoma: a Gynecologic Oncology Group trial.
    Soper JT, Reisinger SA, Ashbury R, Jones E, Clarke-Pearson DL.
    Gynecol Oncol; 2004 Oct; 95(1):95-100. PubMed ID: 15385116
    [Abstract] [Full Text] [Related]

  • 4. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL.
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [Abstract] [Full Text] [Related]

  • 5. Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: a phase I/II study of the Gynecologic Oncology Group.
    DiSilvestro PA, Walker JL, Morrison A, Rose PG, Homesley H, Warshal D, Gynecologic Oncology Group.
    Gynecol Oncol; 2006 Dec; 103(3):1038-42. PubMed ID: 16889823
    [Abstract] [Full Text] [Related]

  • 6. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T, Becker A, Pigorsch S, Pelz T, Bloching M, Passmann M, Lotterer E, Hänsgen G, Dunst J.
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [Abstract] [Full Text] [Related]

  • 7. Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer.
    Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T, Radiation Therapy Oncology Group.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):168-73. PubMed ID: 15093913
    [Abstract] [Full Text] [Related]

  • 8. Maximum tolerated dose and early response - results of a phase I trial of paclitaxel and cisplatin with radiation therapy in carcinoma of the cervix.
    Prasad E, Viswanathan PN, Rangad VF, Pavamani S, Ram TS.
    Clin Oncol (R Coll Radiol); 2009 Aug 01; 21(6):488-93. PubMed ID: 19386478
    [Abstract] [Full Text] [Related]

  • 9. Sequential chemotherapy and irradiation in advanced stage endometrial cancer: A Gynecologic Oncology Group phase I trial of doxorubicin-cisplatin followed by whole abdomen irradiation.
    Fowler JM, Brady WE, Grigsby PW, Cohn DE, Mannel RS, Rader JS.
    Gynecol Oncol; 2009 Mar 01; 112(3):553-7. PubMed ID: 19135232
    [Abstract] [Full Text] [Related]

  • 10. Adjuvant paclitaxel and carboplatin chemotherapy with involved field radiation in advanced endometrial cancer: a sequential approach.
    Lupe K, Kwon J, D'Souza D, Gawlik C, Stitt L, Whiston F, Nascu P, Wong E, Carey MS.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):110-6. PubMed ID: 17084542
    [Abstract] [Full Text] [Related]

  • 11. Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy.
    Brenner B, Ilson DH, Minsky BD, Bains MS, Tong W, Gonen M, Kelsen DP.
    J Clin Oncol; 2004 Jan 01; 22(1):45-52. PubMed ID: 14701767
    [Abstract] [Full Text] [Related]

  • 12. Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer.
    Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T.
    Gynecol Oncol; 2006 Oct 01; 103(1):155-9. PubMed ID: 16545437
    [Abstract] [Full Text] [Related]

  • 13. A phase I study of weekly cisplatin and whole abdominal radiation for the treatment of stage III and IV endometrial carcinoma: a Gynecologic Oncology Group pilot study.
    Reisinger SA, Asbury R, Liao SY, Homesley HD.
    Gynecol Oncol; 1996 Dec 01; 63(3):299-303. PubMed ID: 8946862
    [Abstract] [Full Text] [Related]

  • 14. Concomitant radiotherapy and paclitaxel for high-risk endometrial cancer: first feasibility study.
    Frigerio L, Mangili G, Aletti G, Carnelli M, Garavaglia E, Beatrice S, Ferrari A.
    Gynecol Oncol; 2001 Apr 01; 81(1):53-7. PubMed ID: 11277649
    [Abstract] [Full Text] [Related]

  • 15. Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multi-institutional trial.
    Cmelak AJ, Murphy BA, Burkey B, Douglas S, Shyr Y, Netterville J.
    Head Neck; 2007 Apr 01; 29(4):315-24. PubMed ID: 17252600
    [Abstract] [Full Text] [Related]

  • 16. Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial.
    Loibl S, Murmann C, Schwedler K, Warm M, Müller L, Heinrich G, Nekljudova V, von Minckwitz G.
    Cancer Chemother Pharmacol; 2009 Apr 01; 63(5):953-8. PubMed ID: 18716777
    [Abstract] [Full Text] [Related]

  • 17. A phase I study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): an NRG Oncology/Gynecologic Oncology Group study.
    McMeekin DS, Sill MW, Walker JL, Moore KN, Waggoner SE, Thaker PH, Rizack T, Hoffman JS, Fracasso PM.
    Gynecol Oncol; 2015 Jul 01; 138(1):36-40. PubMed ID: 25958319
    [Abstract] [Full Text] [Related]

  • 18. Phase I/II trial of combination therapy with S-1 and weekly paclitaxel in patients with unresectable or recurrent gastric cancer.
    Inada S, Tomidokoro T, Fukunari H, Sato T, Hatano T, Nishimura A, Kawauchi Y, Nikkuni K, Shimizu T, Sato T, Yanagi M, Takahashi S, Yoshida H, Sugita M, Hayashi T.
    Cancer Chemother Pharmacol; 2009 Jan 01; 63(2):267-73. PubMed ID: 18379784
    [Abstract] [Full Text] [Related]

  • 19. Phase I trial of concomitant vinorelbine, cisplatin, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies.
    Mundt AJ, Rotmensch J, Waggoner SE, Yamada SD, Fleming GF.
    Gynecol Oncol; 2004 Mar 01; 92(3):801-5. PubMed ID: 14984944
    [Abstract] [Full Text] [Related]

  • 20. Phase I study of oral S-1 plus Cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
    Kaira K, Sunaga N, Yanagitani N, Kawata T, Utsugi M, Shimizu K, Ebara T, Kawamura H, Nonaka T, Ishikawa H, Sakurai H, Suga T, Hara K, Hisada T, Ishizuka T, Nakano T, Mori M.
    Int J Radiat Oncol Biol Phys; 2009 Sep 01; 75(1):109-14. PubMed ID: 18929446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.